NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/02/2026
Voltar para busca
Dado oficial do USPTO
GRAYSPACE THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
GRAYSPACE THERAPEUTICS
ST13
US500000088873267Classe
5
Pedido
88873267
Registro
8140236
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
82
Atualização mais recente
17/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
15/04/2020
Data de registro
17/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/02/2026
Última transação
17/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Saskatoon, SK, CA
Examinador
LOVELACE, JAMES B
Unidade examinadora
N10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Med-Life Discoveries GP Inc.
Representantes
Roger H. Bora Thompson Hine LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Synthesized plasmalogen-based therapeutic compounds for the treatment of Alzheimer's DiseaseParkinson's Disease and other neurological indications that have a plasmalogen deficiency
Publicações
Histórico de despachos e eventos da marca no USPTO.
82 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
17/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/12/2025
PUBO
PUBLISHED FOR OPPOSITION
30/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/10/2025
GNRT
NON-FINAL ACTION E-MAILED
08/10/2025
CNRT
NON-FINAL ACTION WRITTEN
08/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/09/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
24/09/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/04/2025
GNSL
LETTER OF SUSPENSION E-MAILED
28/04/2025
CNSL
SUSPENSION LETTER WRITTEN
28/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/04/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/04/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
29/01/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
29/01/2025
CNSI
SUSPENSION INQUIRY WRITTEN
29/01/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
16/01/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
29/02/2024
GNSL
LETTER OF SUSPENSION E-MAILED
29/02/2024
CNSL
SUSPENSION LETTER WRITTEN
29/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/02/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
28/02/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
22/02/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
22/02/2024
CNSI
SUSPENSION INQUIRY WRITTEN
22/02/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
16/02/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/08/2023
GNSL
LETTER OF SUSPENSION E-MAILED
15/08/2023
CNSL
SUSPENSION LETTER WRITTEN
15/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
14/08/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
19/07/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
19/07/2023
CNSI
SUSPENSION INQUIRY WRITTEN
19/07/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
18/07/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/12/2022
GNSL
LETTER OF SUSPENSION E-MAILED
15/12/2022
CNSL
SUSPENSION LETTER WRITTEN
15/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/12/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/12/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
23/11/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
23/11/2022
CNSI
SUSPENSION INQUIRY WRITTEN
23/11/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
18/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/04/2022
GNSL
LETTER OF SUSPENSION E-MAILED
07/04/2022
CNSL
SUSPENSION LETTER WRITTEN
07/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2022
ALIE
ASSIGNED TO LIE
01/04/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30/03/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/10/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/10/2021
CNSI
SUSPENSION INQUIRY WRITTEN
05/10/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/10/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
19/03/2021
GNSL
LETTER OF SUSPENSION E-MAILED
19/03/2021
CNSL
SUSPENSION LETTER WRITTEN
19/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/03/2021
ALIE
ASSIGNED TO LIE
18/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/12/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
16/09/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
16/09/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/07/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/07/2020
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
07/07/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
07/07/2020
DOCK
ASSIGNED TO EXAMINER
06/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/04/2020
NWAP
NEW APPLICATION ENTERED
18/04/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GRAYSPACE THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.